ImmuCell Corp logo

ImmuCell Corp

$ 7.48 -0.085 (-1.12%) 04:00 PM EST
P/E:
249.34
P/B:
1.76
Market Cap:
$ 57.95M
Enterprise V:
$ 59.34M
Volume:
2.37K
Avg Vol (2M):
9.23K
Also Trade In:
Volume:
2.37K
Market Cap $:
57.95M
PE Ratio:
249.34
Avg Vol (2-Month):
9.23K
Enterprise Value $:
59.34M
PB Ratio:
1.76
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The firm has developed products that provide immediate immunity to newborn dairy and beef cattle and is developing product line extensions of its existing products that address mastitis. Its lead product, First Defense, is manufactured to prevent scours in newborn calves. The company generates the majority of its revenue from the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 0.94
Equity-to-Asset 0.71
Debt-to-Equity 0.36
Debt-to-EBITDA 3.83
Interest Coverage 1.84
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.42
Distress
Grey
Safe
Beneish M-Score -2.95
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 35.7
9-Day RSI 42.26
14-Day RSI 43.79
6-1 Month Momentum % -22.76
12-1 Month Momentum % -19.31

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.91
Quick Ratio 5.07
Cash Ratio 4.4
Days Inventory 111.01
Days Sales Outstanding 40.09
Days Payable 22.53

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.6

Financials (Next Earnings Date:2022-11-15 Est.)

ICCC's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ICCC

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 20.455
EPS (TTM) ($) 0.03
Beta 0.65
Volatility % 34.32
14-Day RSI 43.79
14-Day ATR ($) 0.47213
20-Day SMA ($) 7.661795
12-1 Month Momentum % -19.31
52-Week Range ($) 6.96 - 10.96
Shares Outstanding (Mil) 7.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ImmuCell Corp Filings

Document Form Filing Date
No Filing Data

ImmuCell Corp Analysis

Share your research

Headlines

See More
No news.